{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:21:27Z","timestamp":1790688087248,"version":"4.1.0"},"reference-count":89,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","award":["959470"],"award-info":[{"award-number":["959470"]}],"id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010767","name":"Schweizerische Stiftung f\u00fcr die Erforschung der Muskelkrankheiten","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013348","name":"Innosuisse Swiss Innovation Agency","doi-asserted-by":"publisher","award":["34870.1 IP-LS"],"award-info":[{"award-number":["34870.1 IP-LS"]}],"id":[{"id":"10.13039\/501100013348","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ymthe.2026.01.041","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:12:24Z","timestamp":1770077544000},"page":"2818-2839","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Dual AAV gene therapy using laminin-linking proteins ameliorates muscle and nerve defects in LAMA2-related muscular dystrophy"],"prefix":"10.1016","volume":"34","author":[{"given":"Judith R.","family":"Reinhard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Maino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Ham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4974-9384","authenticated-orcid":false,"given":"Markus A.","family":"R\u00fcegg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.01.041_bib1","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1146\/annurev-cellbio-101011-155750","article-title":"Functional diversity of laminins","volume":"28","author":"Domogatskaya","year":"2012","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.ymthe.2026.01.041_bib2","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a004911","article-title":"Basement membranes: cell scaffoldings and signaling platforms","volume":"3","author":"Yurchenco","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.ymthe.2026.01.041_bib3","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1073\/pnas.85.5.1544","article-title":"Merosin, a protein specific for basement membranes of Schwann cells, striated muscle, and trophoblast, is expressed late in nerve and muscle development","volume":"85","author":"Leivo","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.01.041_bib4","first-page":"351","article-title":"Congenital muscular dystrophy with merosin deficiency","volume":"317","author":"Tome","year":"1994","journal-title":"C R. Acad. Sci."},{"key":"10.1016\/j.ymthe.2026.01.041_bib5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.nmd.2010.02.001","article-title":"Genotype-phenotype correlation in a large population of muscular dystrophy patients with LAMA2 mutations","volume":"20","author":"Geranmayeh","year":"2010","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymthe.2026.01.041_bib6","first-page":"1238","article-title":"An international retrospective early natural history study of LAMA2-related dystrophies","volume":"11","author":"Hinkley","year":"2024","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.ymthe.2026.01.041_bib7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fnmol.2020.00123","article-title":"LAMA2-Related Dystrophies: Clinical Phenotypes, Disease Biomarkers, and Clinical Trial Readiness","volume":"13","author":"Sarkozy","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ymthe.2026.01.041_bib8","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1002\/acn3.51172","article-title":"LAMA2-related muscular dystrophy: Natural history of a large pediatric cohort","volume":"7","author":"Zambon","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.ymthe.2026.01.041_bib9","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/s13023-021-01950-x","article-title":"Natural history and genetic study of LAMA2-related muscular dystrophy in a large Chinese cohort","volume":"16","author":"Tan","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymthe.2026.01.041_bib10","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.nmd.2013.12.011","article-title":"Diagnostic approach to the congenital muscular dystrophies","volume":"24","author":"Bonnemann","year":"2014","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymthe.2026.01.041_bib11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3389\/fnmol.2020.00059","article-title":"A Family of Laminin alpha2 Chain-Deficient Mouse Mutants: Advancing the Research on LAMA2-CMD","volume":"13","author":"Gawlik","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ymthe.2026.01.041_bib12","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3389\/fnmol.2020.00060","article-title":"LAMA2 Neuropathies: Human Findings and Pathomechanisms From Mouse Models","volume":"13","author":"Previtali","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ymthe.2026.01.041_bib13","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1006\/mthe.2001.0441","article-title":"Risk and prevention of anti-factor IX formation in AAV-mediated gene transfer in the context of a large deletion of F9","volume":"4","author":"Fields","year":"2001","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.01.041_bib14","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMc2212912","article-title":"Dystrophin Immunity after Gene Therapy for Duchenne's Muscular Dystrophy","volume":"388","author":"Bonnemann","year":"2023","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.01.041_bib15","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1038\/mt.2009.159","article-title":"Impact of the underlying mutation and the route of vector administration on immune responses to factor IX in gene therapy for hemophilia B","volume":"17","author":"Cao","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.01.041_bib16","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJMoa1000228","article-title":"Dystrophin immunity in Duchenne's muscular dystrophy","volume":"363","author":"Mendell","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.01.041_bib17","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/ana.410400515","article-title":"Congenital muscular dystrophy with primary laminin alpha2 (merosin) deficiency presenting as inflammatory myopathy","volume":"40","author":"Pegoraro","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymthe.2026.01.041_bib18","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0960-8966(00)00203-0","article-title":"Massive muscle cell degeneration in the early stage of merosin-deficient congenital muscular dystrophy","volume":"11","author":"Hayashi","year":"2001","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymthe.2026.01.041_bib19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/bs.ctm.2015.05.002","article-title":"Laminin-alpha2 Chain-Deficient Congenital Muscular Dystrophy: Pathophysiology and Development of Treatment","volume":"76","author":"Durbeej","year":"2015","journal-title":"Curr. Top. Membr."},{"key":"10.1016\/j.ymthe.2026.01.041_bib20","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0960-8966(99)00033-4","article-title":"Distribution of ten laminin chains in dystrophic and regenerating muscles","volume":"9","author":"Patton","year":"1999","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymthe.2026.01.041_bib21","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal4649","article-title":"Linker proteins restore basement membrane and correct LAMA2-related muscular dystrophy in mice","volume":"9","author":"Reinhard","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.01.041_bib22","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/emboj\/17.2.335","article-title":"Electron microscopic structure of agrin and mapping of its binding site in laminin-1","volume":"17","author":"Denzer","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.ymthe.2026.01.041_bib23","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0896-6273(00)80096-3","article-title":"Alternative splicing of agrin alters its binding to heparin, dystroglycan, and the putative agrin receptor","volume":"16","author":"Gesemann","year":"1996","journal-title":"Neuron"},{"key":"10.1016\/j.ymthe.2026.01.041_bib24","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1046\/j.1471-4159.2002.01102.x","article-title":"Mapping sites responsible for interactions of agrin with neurons","volume":"83","author":"Burgess","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymthe.2026.01.041_bib25","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1242\/dev.124.19.3909","article-title":"Integrins mediate adhesion to agrin and modulate agrin signaling","volume":"124","author":"Martin","year":"1997","journal-title":"Development"},{"key":"10.1016\/j.ymthe.2026.01.041_bib26","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.celrep.2019.06.036","article-title":"A Role of Agrin in Maintaining the Stability of Vascular Endothelial Growth Factor Receptor-2 during Tumor Angiogenesis","volume":"28","author":"Njah","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2026.01.041_bib27","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0896-6273(92)90090-Z","article-title":"The agrin gene codes for a family of basal lamina proteins that differ in function and distribution","volume":"8","author":"Ruegg","year":"1992","journal-title":"Neuron"},{"key":"10.1016\/j.ymthe.2026.01.041_bib28","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/0896-6273(92)90129-2","article-title":"RNA splicing regulates agrin-mediated acetylcholine receptor clustering activity on cultured myotubes","volume":"8","author":"Ferns","year":"1992","journal-title":"Neuron"},{"key":"10.1016\/j.ymthe.2026.01.041_bib29","doi-asserted-by":"crossref","first-page":"8984","DOI":"10.1074\/jbc.M809719200","article-title":"Scaffold-forming and Adhesive Contributions of Synthetic Laminin-binding Proteins to Basement Membrane Assembly","volume":"284","author":"McKee","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2026.01.041_bib30","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/6981","article-title":"Synthetic muscle promoters: activities exceeding naturally occurring regulatory sequences","volume":"17","author":"Li","year":"1999","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.01.041_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms16105","article-title":"Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy","volume":"8","author":"Le Guiner","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.01.041_bib32","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1083\/jcb.139.6.1507","article-title":"Distribution and function of laminins in the neuromuscular system of developing, adult, and mutant mice","volume":"139","author":"Patton","year":"1997","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ymthe.2026.01.041_bib33","doi-asserted-by":"crossref","first-page":"5432","DOI":"10.1038\/s41467-020-19230-w","article-title":"Identification of a myotropic AAV by massively parallel in vivo evaluation of barcoded capsid variants","volume":"11","author":"Weinmann","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.01.041_bib34","doi-asserted-by":"crossref","DOI":"10.1093\/pnasnexus\/pgad083","article-title":"Nerve pathology is prevented by linker proteins in mouse models for LAMA2-related muscular dystrophy","volume":"2","author":"Reinhard","year":"2023","journal-title":"PNAS Nexus"},{"key":"10.1016\/j.ymthe.2026.01.041_bib35","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1172\/JCI3705","article-title":"Merosin-deficient congenital muscular dystrophy. Partial genetic correction in two mouse models","volume":"102","author":"Kuang","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2026.01.041_bib36","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1083\/jcb.200411158","article-title":"Coordinate control of axon defasciculation and myelination by laminin-2 and -8","volume":"168","author":"Yang","year":"2005","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ymthe.2026.01.041_bib37","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.58591","article-title":"Transcriptional profiling of mouse peripheral nerves to the single-cell level to build a sciatic nerve ATlas (SNAT)","volume":"10","author":"Gerber","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.ymthe.2026.01.041_bib38","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst."},{"key":"10.1016\/j.ymthe.2026.01.041_bib39","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.158397","article-title":"Amelioration of muscle and nerve pathology of Lama2-related dystrophy by AAV9-laminin-alphaLN linker protein","volume":"7","author":"McKee","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymthe.2026.01.041_bib40","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1089\/hum.2010.245","article-title":"Optimizing promoters for recombinant adeno-associated virus-mediated gene expression in the peripheral and central nervous system using self-complementary vectors","volume":"22","author":"Gray","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2026.01.041_bib41","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abn4704","article-title":"Semirational bioengineering of AAV vectors with increased potency and specificity for systemic gene therapy of muscle disorders","volume":"8","author":"El Andari","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ymthe.2026.01.041_bib42","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/s41467-017-01146-7","article-title":"Reducing sarcolipin expression mitigates Duchenne muscular dystrophy and associated cardiomyopathy in mice","volume":"8","author":"Voit","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.01.041_bib43","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1002\/acn3.51450","article-title":"Transcriptome analysis of collagen VI-related muscular dystrophy muscle biopsies","volume":"8","author":"Guadagnin","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.ymthe.2026.01.041_bib44","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.01.041_bib45","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/2044-5040-4-14","article-title":"Dysregulation of matricellular proteins is an early signature of pathology in laminin-deficient muscular dystrophy","volume":"4","author":"Mehuron","year":"2014","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.ymthe.2026.01.041_bib46","doi-asserted-by":"crossref","first-page":"24760","DOI":"10.1074\/jbc.M801166200","article-title":"Cib2 binds integrin alpha7Bbeta1D and is reduced in laminin alpha2 chain-deficient muscular dystrophy","volume":"283","author":"Hager","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2026.01.041_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/srep44059","article-title":"Potent pro-inflammatory and pro-fibrotic molecules, osteopontin and galectin-3, are not major disease modulators of laminin alpha2 chain-deficient muscular dystrophy","volume":"7","author":"Gawlik","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2026.01.041_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmd.2024.07.287","article-title":"RGX-202, an investigational gene therapy for the treatment of Duchenne muscular dystrophy: interim clinical data","volume":"43","author":"Dastgir","year":"2024","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymthe.2026.01.041_bib49","article-title":"GNT0004, Genethon\u2019s AAV8 vector-delivered microdystrophin gene therapy of Duchenne muscular dystrophy, first data of the phase I\/II part of the GNT-016-MDYF all-in-one clinical trial in ambulant boys","volume":"53","author":"Laugel","year":"2024","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymthe.2026.01.041_bib50","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/mt.2008.76","article-title":"Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection","volume":"16","author":"Zincarelli","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.01.041_bib51","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1016\/j.ymthe.2025.03.037","article-title":"The curious case of AAV immunology","volume":"33","author":"Keeler","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.01.041_bib52","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1016\/j.ymthe.2025.06.032","article-title":"Complement activation in a phase Ib study of fordadistrogene movaparvovec for Duchenne muscular dystrophy","volume":"33","author":"Byrne","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.01.041_bib53","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jpeds.2020.11.054","article-title":"Thrombotic Microangiopathy Following Onasemnogene Abeparvovec for Spinal Muscular Atrophy: A Case Series","volume":"231","author":"Chand","year":"2021","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymthe.2026.01.041_bib54","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/35095054","article-title":"An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy","volume":"413","author":"Moll","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.01.041_bib55","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1083\/jcb.200611152","article-title":"Linker molecules between laminins and dystroglycan ameliorate laminin-alpha2-deficient muscular dystrophy at all disease stages","volume":"176","author":"Meinen","year":"2007","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ymthe.2026.01.041_bib56","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1096\/fj.04-3376com","article-title":"Overexpression of mini-agrin in skeletal muscle increases muscle integrity and regenerative capacity in laminin-alpha2-deficient mice","volume":"19","author":"Bentzinger","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.ymthe.2026.01.041_bib57","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/mus.10544","article-title":"EMG and nerve conduction studies in children with congenital muscular dystrophy","volume":"29","author":"Quijano-Roy","year":"2004","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymthe.2026.01.041_bib58","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/mus.10326","article-title":"Dysmyelinating sensory-motor neuropathy in merosin-deficient congenital muscular dystrophy","volume":"27","author":"Di Muzio","year":"2003","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymthe.2026.01.041_bib59","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.nmd.2014.05.008","article-title":"Limb girdle muscular dystrophy due to LAMA2 mutations: diagnostic difficulties due to associated peripheral neuropathy","volume":"24","author":"Chan","year":"2014","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymthe.2026.01.041_bib60","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1177\/088307389501000610","article-title":"Demyelinating peripheral neuropathy in merosin-deficient congenital muscular dystrophy","volume":"10","author":"Shorer","year":"1995","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.ymthe.2026.01.041_bib61","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.omtm.2018.01.005","article-title":"Amelioration of Muscle and Nerve Pathology in LAMA2 Muscular Dystrophy by AAV9-Mini-Agrin","volume":"9","author":"Qiao","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.01.041_bib62","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1093\/hmg\/ddl201","article-title":"Laminin alpha1 chain improves laminin alpha2 chain deficient peripheral neuropathy","volume":"15","author":"Gawlik","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2026.01.041_bib63","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41586-019-1430-x","article-title":"A mutation-independent approach for muscular dystrophy via upregulation of a modifier gene","volume":"572","author":"Kemaladewi","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.01.041_bib64","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fnmol.2020.00003","article-title":"Fibrogenesis in LAMA2-Related Muscular Dystrophy Is a Central Tenet of Disease Etiology","volume":"13","author":"Accorsi","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ymthe.2026.01.041_bib65","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1172\/JCI22928","article-title":"Inhibition of apoptosis improves outcome in a model of congenital muscular dystrophy","volume":"114","author":"Girgenrath","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2026.01.041_bib66","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1074\/mcp.M113.032276","article-title":"Quantitative proteomic analysis reveals metabolic alterations, calcium dysregulation, and increased expression of extracellular matrix proteins in laminin alpha2 chain-deficient muscle","volume":"13","author":"de Oliveira","year":"2014","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.ymthe.2026.01.041_bib67","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1093\/hmg\/ddh190","article-title":"Laminin alpha1 chain reduces muscular dystrophy in laminin alpha2 chain deficient mice","volume":"13","author":"Gawlik","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2026.01.041_bib68","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/j.ajpath.2011.12.019","article-title":"Laminin-111 protein therapy reduces muscle pathology and improves viability of a mouse model of merosin-deficient congenital muscular dystrophy","volume":"180","author":"Rooney","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymthe.2026.01.041_bib69","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.omtm.2021.02.004","article-title":"Micro-laminin gene therapy can function as an inhibitor of muscle disease in the dy(W) mouse model of MDC1A","volume":"21","author":"Packer","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.01.041_bib70","doi-asserted-by":"crossref","first-page":"6374","DOI":"10.1038\/s41467-020-20063-w","article-title":"Single-nucleus RNA-seq identifies transcriptional heterogeneity in multinucleated skeletal myofibers","volume":"11","author":"Petrany","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.01.041_bib71","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1038\/s41467-025-57487-1","article-title":"Single-nuclei sequencing of skeletal muscle reveals subsynaptic-specific transcripts involved in neuromuscular junction maintenance","volume":"16","author":"Ham","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.01.041_bib72","doi-asserted-by":"crossref","DOI":"10.1126\/science.abl4290","article-title":"Single-nucleus cross-tissue molecular reference maps toward understanding disease gene function","volume":"376","author":"Eraslan","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.01.041_bib73","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-65703-1","article-title":"Loss of cell-autonomously secreted laminin-alpha2 drives muscle stem cell dysfunction in LAMA2-related muscular dystrophy","volume":"16","author":"McGowan","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.01.041_bib74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnmol.2020.00001","article-title":"Laminin and Integrin in LAMA2-Related Congenital Muscular Dystrophy: From Disease to Therapeutics","volume":"13","author":"Barraza-Flores","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ymthe.2026.01.041_bib75","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/mus.26329","article-title":"Evidence of induced muscle regeneration persists for years in the mouse","volume":"58","author":"Meyer","year":"2018","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymthe.2026.01.041_bib76","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.devcel.2024.03.017","article-title":"Three-dimensional imaging studies in mice identify cellular dynamics of skeletal muscle regeneration","volume":"59","author":"Collins","year":"2024","journal-title":"Dev. Cell"},{"key":"10.1016\/j.ymthe.2026.01.041_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2023.101144","article-title":"Persistence of exon 2 skipping and dystrophin expression at 18 months after U7snRNA-mediated therapy in the Dup2 mouse model","volume":"31","author":"Gushchina","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.01.041_bib78","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S1474-4422(23)00313-7","article-title":"Safety and efficacy of gene replacement therapy for X-linked myotubular myopathy (ASPIRO): a multinational, open-label, dose-escalation trial","volume":"22","author":"Shieh","year":"2023","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ymthe.2026.01.041_bib79","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1016\/j.nmd.2023.07.035","article-title":"T-cell response to SRP-9001 dystrophin transgene in a patient treated with Delandistrogene Moxeparvovec: a case of immune-mediated myositis","volume":"33","author":"Khan","year":"2023","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymthe.2026.01.041_bib80","first-page":"1601","article-title":"Activation of the lama2 gene in muscle regeneration: abortive regeneration in laminin alpha2-deficiency","volume":"79","author":"Kuang","year":"1999","journal-title":"Lab. Invest."},{"key":"10.1016\/j.ymthe.2026.01.041_bib81","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1006\/dbio.2002.0597","article-title":"Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation\/inactivation in the mouse","volume":"244","author":"Hayashi","year":"2002","journal-title":"Dev. Biol."},{"key":"10.1016\/j.ymthe.2026.01.041_bib82","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1002\/biot.201400046","article-title":"CRISPR\/Cas9-mediated genome engineering: an adeno-associated viral (AAV) vector toolbox","volume":"9","author":"Senis","year":"2014","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.ymthe.2026.01.041_bib83","doi-asserted-by":"crossref","first-page":"6116","DOI":"10.1038\/s41467-023-41769-7","article-title":"Fast, multiplexable and efficient somatic gene deletions in adult mouse skeletal muscle fibers using AAV-CRISPR\/Cas9","volume":"14","author":"Thurkauf","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.01.041_bib84","article-title":"Intravenous injections in neonatal mice","volume":"93","author":"Gombash Lampe","year":"2014","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.ymthe.2026.01.041_bib85","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S0960-8966(03)00036-1","article-title":"Expression of mouse agrin in normal, denervated and dystrophic muscle","volume":"13","author":"Eusebio","year":"2003","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymthe.2026.01.041_bib86","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1172\/JCI90854","article-title":"Chimeric protein repair of laminin polymerization ameliorates muscular dystrophy phenotype","volume":"127","author":"McKee","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2026.01.041_bib87","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.nmd.2004.06.008","article-title":"Histological parameters for the quantitative assessment of muscular dystrophy in the mdx-mouse","volume":"14","author":"Briguet","year":"2004","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymthe.2026.01.041_bib88","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229041","article-title":"Myosoft: An automated muscle histology analysis tool using machine learning algorithm utilizing FIJI\/ImageJ software","volume":"15","author":"Encarnacion-Rivera","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2026.01.041_bib89","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1113\/jphysiol.1988.sp017279","article-title":"Contractile properties of skeletal muscles from young, adult and aged mice","volume":"404","author":"Brooks","year":"1988","journal-title":"J. Physiol."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626000845?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626000845?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:34:50Z","timestamp":1781829290000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626000845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":89,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1525001626000845"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.01.041","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual AAV gene therapy using laminin-linking proteins ameliorates muscle and nerve defects in LAMA2-related muscular dystrophy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.01.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}